koolgal
15:17
๐ŸŒŸTalk about financial whiplash!  What will go down as biotech history is $Moderna, Inc.(MRNA)$ .  The stock surged an unbelievable 177% yesterday on explosive Phase 3 cancer vaccine validation volume, only to get hit by a savage, profit taking meat grinder today.  Moderna plunged 23.55% plus another 2.76% in after hours trading.

Is this explosive wave of Moderna momentum dead or just a temporary setback before it continues its upward momentum?

I find that it is less stressful to just invest in $Health Care Select Sector SPDR Fund(XLV)$ of which Moderna is one of the holdings.  The top holdings include $Eli Lilly(LLY)$ $Johnson & Johnson(JNJ)$ $AbbVie(ABBV)$ & $UnitedHealth(UNH)$

For a low expense ratio of just 0.08% ,XLV strips away the heavy fees associated with active thematic trading, making it one of the most cost efficient funds on Wall Street.

XLV also pays a dividend yield of 1.6%.

Investing does not have to be stressful with XLV.

@Tiger_comments @TigerStars

The boss asked me to issue coins
Hello everyone! Today is the eve of the "US Stock Earnings Week War", and it is also the first day of this tiger! To be honest, the boss stuffed a pocket of tiger coins as soon as he entered the office, and gave a death order: "If you can't finish it in a month, don't think about getting off work!" In order to get off work early and eat hot pot, I will hold fresh topics here every day and wait for everyone. As long as you dare to talk, I dare to send it! Look directly at today's hot discussion ๐Ÿ‘‡ ๐Ÿ”ฅ The Nasdaq 100 fell 1.1%. Should the Fed FOMC + Big Four be safe from earnings week?
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment
1